Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

United Guardian Inc (NQ: UG )

7.860 UNCHANGED
Streaming Delayed Price Updated: 3:23 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about United Guardian Inc

UG Stock Earnings: United-Guardian Reported Results for Q4 2023
United-Guardian just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Why United-Guardian Shares Are Rising Today
United-Guardian shares rise after the company announces a dividend increase to $0.25 per share. The company plans for enhanced marketing strategies in 2024. 
Via Benzinga
Dividends By The Numbers In July 2023
July 2023's dividends started off the third quarter of 2023 the way June 2023's dividends ended the second quarter. Unimpressively. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Monday
  On Monday, 50 companies reached new 52-week lows. 
Via Benzinga
Sleep Apnea Device Maker Resmed Sees Improved Relative Strength
Resmed shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 325 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  During Monday's session, 402 companies made new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 127 companies set new 52-week lows. 
Via Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. 
Via Benzinga
Dividends By The Numbers In May 2022
Dividend-paying firms in the U.S. showed unexpected strength in May. 
Via Talk Markets
58 Biggest Movers From Yesterday
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million. 
Via Benzinga
Establishment Labs Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating
Establishment Labs stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 92, up from 87 the day before. 
Via Investor's Business Daily
Inspire Medical Systems Stock Scores Relative Strength Rating Upgrade
Inspire Medical System stock reached an key technical benchmark, seeing its Relative Strength (RS) Rating jumping to 91. 
Via Investor's Business Daily
The Commodities Feed: Growth Concerns Weigh On Oil
Demand concerns weighed on oil yesterday, following the IMF downgrading global economic growth on the back of the Russia-Ukraine war and Covid related lockdowns in parts of China. 
Via Talk Markets
The Commodities Feed: Choppy price action continues
Whipsawing in the oil market continues, with ICE Brent rebounding yesterday to settle more than 6% up on the day. 
Via Talk Markets
Lantheus Sees Composite Rating Move Up To 96; Stock Rockets To New Highs
Medical imaging Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 96. 
Via Investor's Business Daily
United-Guardian Clocks 36% Revenue Growth In Q3
United-Guardian Inc (NASDAQ: UG) reported third-quarter FY21 sales of $3.18 million, a 36.1% year-on-year growth. Operating expenses declined 7% Y/Y to $0.46 million.... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.